Comments
Loading...

CME Group Analyst Ratings

CMENASDAQ
Logo brought to you by Benzinga Data
$254.46
At close: Apr 4, 4:47 PM EDT
$254.46
0.000.00%
After Hours: Apr 4, 4:47 PM EDT
Consensus Rating1
Outperform
Highest Price Target1
$287.00
Lowest Price Target1
$187.00
Consensus Price Target1
$234.33

CME Group Analyst Ratings and Price Targets | NASDAQ:CME | Benzinga

CME Group Inc has a consensus price target of $234.33 based on the ratings of 21 analysts. The high is $287 issued by Raymond James on March 10, 2025. The low is $187 issued by Rosenblatt on April 25, 2024. The 3 most-recent analyst ratings were released by RBC Capital, B of A Securities, and Raymond James on April 3, 2025, April 2, 2025, and March 10, 2025, respectively. With an average price target of $258.33 between RBC Capital, B of A Securities, and Raymond James, there's an implied 1.52% upside for CME Group Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Dec 24
1
2
Jan
1
3
1
Feb
1
Mar
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

RBC Capital
B of A Securities
Raymond James
Morgan Stanley
Keefe, Bruyette & Woods

1calculated from analyst ratings

Analyst Ratings for CME Group

Buy NowGet Alert
04/03/2025Buy Now5.71%RBC Capital
Ashish Sabadra71%
$269 → $269ReiteratesSector Perform → Sector PerformGet Alert
04/02/2025Buy Now-13.94%B of A Securities
Craig Siegenthaler76%
$200 → $219MaintainsUnderperformGet Alert
03/10/2025Buy Now12.79%Raymond James
Patrick O'Shaughnessy75%
→ $287UpgradeMarket Perform → OutperformGet Alert
02/19/2025Buy Now3.36%Morgan Stanley
Mike Cyprys57%
$256 → $263MaintainsEqual-WeightGet Alert
02/14/2025Buy Now1%Keefe, Bruyette & Woods
Kyle Voigt65%
$256 → $257MaintainsMarket PerformGet Alert
02/13/2025Buy Now5.71%RBC Capital
Ashish Sabadra71%
$235 → $269MaintainsSector PerformGet Alert
02/13/2025Buy Now5.71%Oppenheimer
Owen Lau69%
$258 → $269MaintainsOutperformGet Alert
02/13/2025Buy Now-16.69%JP Morgan
Kenneth Worthington61%
$209 → $212MaintainsUnderweightGet Alert
02/13/2025Buy Now3.36%Barclays
Benjamin Budish80%
$257 → $263MaintainsEqual-WeightGet Alert
01/13/2025Buy Now0.61%Keefe, Bruyette & Woods
Kyle Voigt65%
$260 → $256MaintainsMarket PerformGet Alert
01/07/2025Buy Now1.39%Piper Sandler
Patrick Moley80%
$250 → $258MaintainsOverweightGet Alert
01/06/2025Buy Now-7.65%RBC Capital
Ashish Sabadra71%
$235 → $235ReiteratesSector Perform → Sector PerformGet Alert
01/06/2025Buy Now-1.75%Citigroup
Christopher Allen78%
$255 → $250DowngradeBuy → NeutralGet Alert
12/20/2024Buy Now2.18%Keefe, Bruyette & Woods
Kyle Voigt65%
$237 → $260MaintainsMarket PerformGet Alert
12/09/2024Buy Now1%Barclays
Benjamin Budish80%
$231 → $257MaintainsEqual-WeightGet Alert
11/11/2024Buy Now-11.18%Deutsche Bank
Brian Bedell51%
$227 → $226MaintainsHoldGet Alert
10/28/2024Buy Now-1.75%Piper Sandler
Patrick Moley80%
$240 → $250MaintainsOverweightGet Alert
10/24/2024Buy Now-7.65%RBC Capital
Ashish Sabadra71%
$235 → $235ReiteratesSector Perform → Sector PerformGet Alert
10/24/2024Buy Now1.39%Oppenheimer
Owen Lau69%
$245 → $258MaintainsOutperformGet Alert
10/24/2024Buy Now0.21%Citigroup
Christopher Allen78%
$250 → $255MaintainsBuyGet Alert
10/24/2024Buy Now-9.22%Barclays
Benjamin Budish80%
$219 → $231MaintainsEqual-WeightGet Alert
10/17/2024Buy Now-8.43%Morgan Stanley
Mike Cyprys57%
$210 → $233MaintainsEqual-WeightGet Alert
10/14/2024Buy Now-3.72%Oppenheimer
Owen Lau69%
$228 → $245MaintainsOutperformGet Alert
10/08/2024Buy Now-4.11%Redburn Atlantic
Simon Clinch62%
→ $244DowngradeBuy → NeutralGet Alert
10/08/2024Buy Now-5.68%Piper Sandler
Patrick Moley80%
$225 → $240MaintainsOverweightGet Alert
10/07/2024Buy Now-13.94%Barclays
Benjamin Budish80%
$209 → $219MaintainsEqual-WeightGet Alert
10/03/2024Buy Now-1.75%Citigroup
Christopher Allen78%
$240 → $250MaintainsBuyGet Alert
10/03/2024Buy Now-22.19%Goldman Sachs
Alexander Blostein73%
$195 → $198MaintainsSellGet Alert
10/03/2024Buy Now-7.65%RBC Capital
Ashish Sabadra71%
$235 → $235ReiteratesSector Perform → Sector PerformGet Alert
10/03/2024Buy Now-29.26%B of A Securities
Craig Siegenthaler76%
$177 → $180MaintainsUnderperformGet Alert
09/27/2024Buy Now-7.65%RBC Capital
Ashish Sabadra71%
→ $235Initiates → Sector PerformGet Alert
09/26/2024Buy Now-13.15%TD Cowen
Bill Katz68%
→ $221Initiates → HoldGet Alert
09/03/2024Buy Now-30.44%B of A Securities
Craig Siegenthaler76%
$212 → $177DowngradeNeutral → UnderperformGet Alert
08/20/2024Buy Now-11.58%Piper Sandler
Patrick Moley80%
$225 → $225ReiteratesOverweight → OverweightGet Alert
08/15/2024Buy Now-21.4%Deutsche Bank
Brian Bedell51%
$193 → $200MaintainsHoldGet Alert
07/25/2024Buy Now-24.15%Deutsche Bank
Brian Bedell51%
$195 → $193MaintainsHoldGet Alert
07/25/2024Buy Now-24.94%JP Morgan
Kenneth Worthington61%
$187 → $191MaintainsUnderweightGet Alert
07/25/2024Buy Now-16.29%Keefe, Bruyette & Woods
Kyle Voigt65%
$212 → $213MaintainsMarket PerformGet Alert
07/25/2024Buy Now-17.87%Barclays
Benjamin Budish80%
$208 → $209MaintainsEqual-WeightGet Alert
07/25/2024Buy Now-11.58%Piper Sandler
Patrick Moley80%
$235 → $225MaintainsOverweightGet Alert
07/10/2024Buy Now-18.26%Barclays
Benjamin Budish80%
$228 → $208MaintainsEqual-WeightGet Alert
07/09/2024Buy Now-7.65%Piper Sandler
Richard Repetto76%
$250 → $235MaintainsOverweightGet Alert
07/03/2024Buy Now-11.18%Keefe, Bruyette & Woods
Kyle Voigt65%
$226 → $226MaintainsMarket PerformGet Alert
06/21/2024Buy Now-26.51%JP Morgan
Kenneth Worthington61%
$206 → $187DowngradeNeutral → UnderweightGet Alert
04/25/2024Buy Now-10.4%Barclays
Benjamin Budish80%
$226 → $228MaintainsEqual-WeightGet Alert
04/25/2024Buy Now-15.11%B of A Securities
Craig Siegenthaler76%
$209 → $216MaintainsNeutralGet Alert
04/25/2024Buy Now-19.04%JP Morgan
Kenneth Worthington61%
$198 → $206MaintainsNeutralGet Alert
04/25/2024Buy Now-11.18%Keefe, Bruyette & Woods
Kyle Voigt65%
$222 → $226MaintainsMarket PerformGet Alert
04/25/2024Buy Now-26.51%Rosenblatt
Andrew Bond72%
$185 → $187ReiteratesSell → SellGet Alert
04/09/2024Buy Now-11.58%Morgan Stanley
Mike Cyprys57%
$222 → $225MaintainsEqual-WeightGet Alert
04/08/2024Buy Now-11.18%Barclays
Benjamin Budish80%
$225 → $226MaintainsEqual-WeightGet Alert
04/05/2024Buy Now-17.47%Deutsche Bank
Brian Bedell51%
$235 → $210DowngradeBuy → HoldGet Alert
04/03/2024Buy Now-10.01%Keefe, Bruyette & Woods
Kyle Voigt65%
→ $229MaintainsMarket PerformGet Alert
03/06/2024Buy Now-3.72%Argus Research
Kevin Heal63%
$225 → $245MaintainsBuyGet Alert
02/15/2024Buy Now-11.58%Barclays
Benjamin Budish80%
$222 → $225MaintainsEqual-WeightGet Alert
01/08/2024Buy Now-12.76%Barclays
Benjamin Budish80%
$244 → $222DowngradeOverweight → Equal-WeightGet Alert
01/04/2024Buy Now-29.26%Rosenblatt
Andrew Bond72%
→ $180ReiteratesSell → SellGet Alert
01/03/2024Buy Now-23.37%Goldman Sachs
Alexander Blostein73%
→ $195DowngradeNeutral → SellGet Alert
10/26/2023Buy Now-4.11%Barclays
Benjamin Budish80%
$247 → $244MaintainsOverweightGet Alert
10/26/2023Buy Now-13.54%Morgan Stanley
Mike Cyprys57%
$215 → $220MaintainsEqual-WeightGet Alert
10/26/2023Buy Now-29.26%Rosenblatt
Andrew Bond72%
$173 → $180MaintainsSellGet Alert
10/12/2023Buy Now-5.68%Citigroup
Christopher Allen78%
$215 → $240MaintainsBuyGet Alert
10/11/2023Buy Now-22.58%JP Morgan
Kenneth Billingsley41%
$190 → $197MaintainsNeutralGet Alert
10/11/2023Buy Now-15.51%Morgan Stanley
Mike Cyprys57%
$211 → $215MaintainsEqual-WeightGet Alert
10/11/2023Buy Now-5.68%Deutsche Bank
Brian Bedell51%
$224 → $240MaintainsBuyGet Alert
10/10/2023Buy Now-2.93%Barclays
Benjamin Budish80%
$230 → $247MaintainsOverweightGet Alert
10/04/2023Buy Now-32.01%Rosenblatt
Andrew Bond72%
→ $173ReiteratesSell → SellGet Alert
09/06/2023Buy Now-19.83%B of A Securities
Craig Siegenthaler76%
$167 → $204UpgradeUnderperform → NeutralGet Alert
07/27/2023Buy Now-9.61%Barclays
Benjamin Budish80%
$215 → $230MaintainsOverweightGet Alert
07/27/2023Buy Now-21.4%Keefe, Bruyette & Woods
Kyle Voigt65%
$197 → $200MaintainsMarket PerformGet Alert
07/27/2023Buy Now-12.76%Oppenheimer
Owen Lau69%
→ $222ReiteratesOutperform → OutperformGet Alert
07/27/2023Buy Now-17.08%Morgan Stanley
Mike Cyprys57%
$210 → $211MaintainsEqual-WeightGet Alert
07/27/2023Buy Now-15.51%Citigroup
Christopher Allen78%
$210 → $215MaintainsBuyGet Alert
07/27/2023Buy Now-32.01%Rosenblatt
Andrew Bond72%
$169 → $173MaintainsSellGet Alert
07/13/2023Buy Now-17.47%Morgan Stanley
Mike Cyprys57%
$208 → $210MaintainsEqual-WeightGet Alert
07/06/2023Buy Now-17.47%Citigroup
Christopher Allen78%
→ $210ReiteratesBuy → BuyGet Alert
07/06/2023Buy Now-33.58%Rosenblatt
Andrew Bond72%
$161 → $169MaintainsSellGet Alert
06/28/2023Buy Now-15.51%Barclays
Benjamin Budish80%
→ $215Initiates → OverweightGet Alert
04/19/2023Buy Now-23.76%JP Morgan
Kenneth Billingsley41%
$196 → $194MaintainsNeutralGet Alert
04/12/2023Buy Now-13.15%Oppenheimer
Owen Lau69%
$213 → $221MaintainsOutperformGet Alert
04/11/2023Buy Now-18.26%Morgan Stanley
Mike Cyprys57%
$201 → $208MaintainsEqual-WeightGet Alert
04/05/2023Buy Now-36.73%Rosenblatt
Andrew Bond72%
→ $161Reiterates → SellGet Alert
02/13/2023Buy Now-21.01%Morgan Stanley
Michael Cyprys70%
$196 → $201MaintainsEqual-WeightGet Alert
02/09/2023Buy Now-36.73%Rosenblatt
Andrew Bond72%
→ $161Reiterates → SellGet Alert
02/09/2023Buy Now-18.65%Credit Suisse
Gautam Sawant66%
$198 → $207MaintainsOutperformGet Alert
02/07/2023Buy Now-22.19%Credit Suisse
Gautam Sawant66%
$192 → $198MaintainsOutperformGet Alert
01/19/2023Buy Now-16.29%Oppenheimer
Colin Rusch54%
$218 → $213MaintainsOutperformGet Alert
01/11/2023Buy Now-22.97%Morgan Stanley
Michael Cyprys70%
$208 → $196MaintainsEqual-WeightGet Alert
01/05/2023Buy Now-24.94%Credit Suisse
Gautam Sawant66%
→ $191UpgradeNeutral → OutperformGet Alert
12/19/2022Buy Now-1.75%Piper Sandler
Richard Repetto76%
$270 → $250MaintainsOverweightGet Alert
10/27/2022Buy Now-18.26%Morgan Stanley
Michael Cyprys70%
$213 → $208MaintainsEqual-WeightGet Alert
10/12/2022Buy Now-16.29%Morgan Stanley
Michael Cyprys70%
$226 → $213MaintainsEqual-WeightGet Alert
10/12/2022Buy NowDeutsche Bank
Brian Bedell51%
UpgradeHold → BuyGet Alert
10/12/2022Buy Now-13.54%Citigroup
Christopher Allen78%
→ $220Initiates → BuyGet Alert
10/05/2022Buy Now-36.73%Rosenblatt
Andrew Bond72%
$171 → $161MaintainsSellGet Alert
09/06/2022Buy Now-17.47%Credit Suisse
Gautam Sawant66%
$216 → $210MaintainsNeutralGet Alert
08/17/2022Buy Now-32.8%Rosenblatt
Andrew Bond72%
→ $171Initiates → SellGet Alert
08/15/2022Buy NowRaymond James
Patrick O'Shaughnessy75%
DowngradeOutperform → Market PerformGet Alert
08/12/2022Buy Now-16.69%Deutsche Bank
Brian Bedell51%
$208 → $212MaintainsHoldGet Alert
08/03/2022Buy Now-15.11%Credit Suisse
Gautam Sawant66%
$218 → $216MaintainsNeutralGet Alert

FAQ

Q

What is the target price for CME Group (CME) stock?

A

The latest price target for CME Group (NASDAQ:CME) was reported by RBC Capital on April 3, 2025. The analyst firm set a price target for $269.00 expecting CME to rise to within 12 months (a possible 5.71% upside). 51 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for CME Group (CME)?

A

The latest analyst rating for CME Group (NASDAQ:CME) was provided by RBC Capital, and CME Group reiterated their sector perform rating.

Q

When was the last upgrade for CME Group (CME)?

A

The last upgrade for CME Group Inc happened on March 10, 2025 when Raymond James raised their price target to $287. Raymond James previously had a market perform for CME Group Inc.

Q

When was the last downgrade for CME Group (CME)?

A

The last downgrade for CME Group Inc happened on January 6, 2025 when Citigroup changed their price target from $255 to $250 for CME Group Inc.

Q

When is the next analyst rating going to be posted or updated for CME Group (CME)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CME Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CME Group was filed on April 3, 2025 so you should expect the next rating to be made available sometime around April 3, 2026.

Q

Is the Analyst Rating CME Group (CME) correct?

A

While ratings are subjective and will change, the latest CME Group (CME) rating was a reiterated with a price target of $269.00 to $269.00. The current price CME Group (CME) is trading at is $254.46, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch